Julide T Celebi, MD Email Julide Celebi
- PROFESSOR | Pathology
- PROFESSOR | Dermatology
- PROFESSOR | Oncological Sciences
- Anatomic Pathology
- Hospital Affiliation
- The Mount Sinai Hospital
- Mount Sinai Dermatology 212-731-3311212-731-3311
She completed her dermatology residency training at Columbia University’s College of Physicians & Surgeons in New York. She joined the faculty at Columbia University in 1998 and completed translational and basic science research training in cancer genetics. Dr. Celebi is a recipient of numerous prestigious awards; the Women’s Dermatologic Society Mentorship Program Award, the Dermatology Foundation’s Clinical Career Development Award, and the Irving Scholarship from Columbia University. In addition, Dr. Celebi is the recipient of the Skin Cancer Foundation’s Frederick E. Mohs Memorial Award, NIH Mentored Clinical Scientist Award, and numerous Foundation and NIH grants for her groundbreaking work on melanoma. Her laboratory studies focus on the molecular genetics of melanoma. She is an active member of the Tisch Cancer Institute located at the Norma and Leon Hess Center for Science and Medicine.
She is a member of the American Academy of Dermatology, Society for Investigative Dermatology, American Association for Cancer Research, Society for Melanoma Research, and New York Dermatologic Society.
Dr. Celebi’s dermatology expertise includes:
1) Moles and Melanoma: skin cancer screening, melanoma risk assessment and surveillance, state-of-the-art imaging systems such as mole mapping, dermoscopy and MelaFind.
2) General Dermatology
3) Cosmetic Dermatology, Skin Health and Appearance: Botox and filler injections, chemical peels and laser surgery.
Dr. Celebi is an exceptional leader, a brilliant and caring physician, a devoted educator, and an insightful scientist. She sees patients at our eastside location.
Appointments can be made by calling (212) 241-9728 or using the online appointment link on this page.
American Board of Dermatology
- Actinic Keratosis
- Basal Cell Carcinoma
- Botox Cosmetic
- Botulinum Injections-Cosmetic
- Botulinum Toxin Injections
- Botulinum Toxin for Hyperhidrosis
- Botulinum Toxin for Wrinkles
- Clear & Brilliant
- Cosmetic Consultation
- Cosmetic Surgery
- Facial Rejuvenation
- General Dermatology
- Laser Resurfacing
- Obaji Peels
- Seborrheic Keratosis
- Skin Biopsy
- Skin Cancer Screening
- Skin Health Appearance Consultation
- Skin Lesion Removal
- Squamous Cell Carcinoma
Cancer Genetics, Metastasis, Oncogenes, Tumor Suppressor Genes, Tumorigenesis
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Genetics and Genomic Sciences [GGS]
MD, Istanbul University
Internship, Internal Medicine
Shands Hospital, Jacksonville
Notch Inhibition in Melanoma
National Institutes of Health/National Cancer Institute
Improving Diagnostic Precision of Melanoma Using Genetic Information
Melanoma Research Foundation
The Celebi laboratory studies the following topics; Melanoma, Melanoma Precursors, Moles, Oncogenes, Tumor Suppressor Genes, Genomics, Cancer Genetics, and Cancer Biology.
FBXW7 modulates cellular stress response and metastatic potential through HSF1 post-translational modification. Nature Cell Biology 2015 March; 17(3).
FBXW7 mutations in melanloma and a new therapeutic paradigm. Journal of the National Cancer Institute 2014 May; 106(6).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Celebi did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.